البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: VMD (Veterinary Medicines Directorate)
Salmonella enteritidis, Salmonella Infantis, Salmonella typhimurium
MSD Animal Health UK Limited
QI01AB01
Salmonella enteritidis, Salmonella Infantis, Salmonella typhimurium
Suspension for injection
POM-V - Prescription Only Medicine – Veterinarian
Chickens
Inactivated Bacterial Vaccine
Authorized
2020-05-18
Revised: May 2023 AN: 00977/2022 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis Salenvac ETC suspension for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml contains: ACTIVE SUBSTANCES: Inactivated _Salmonella_ Enteritidis, strain PT4: 1 – 6.6 RP* Inactivated_ Salmonella _Typhimurium, strain DT104: 1 – 16.1 RP Inactivated _Salmonella _Infantis, strain A, S03499-06: 1 – 26.6 RP *RP (relative potency): Ratio of antigenic mass (in Units) as compared to the antigenic mass (in Units) of a reference batch which was shown to be efficacious in chickens. ADJUVANT: Aluminium hydroxide: 125 mg EXCIPIENTS: Thiomersal: 0.065 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection. A homogeneous, cream to mid-brown suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (breeders and layers). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of chickens from 6 weeks of age to reduce colonisation and faecal excretion of _S. _Enteritidis (serogroup D), _S. _Typhimurium and _S_. Heidelberg (serogroup B), _S._ Infantis, _S_. Hadar and _S_. Virchow (serogroup C). Revised: May 2023 AN: 00977/2022 Page 2 of 5 Onset of immunity after the second vaccination _S._ Enteritidis, _S._ Typhimurium, _S._ Infantis,_ S. _Hadar and _S. _Virchow: 4 weeks _S._ Heidelberg: 9 weeks* *Earliest timepoint investigated Duration of immunity after the second vaccination _S._ Enteritidis: 48 weeks (evidenced by challenge) and 90 weeks (evidenced by serology) _S._ Typhimurium: 57 weeks (evidenced by challenge) and 90 weeks (evidenced by serology) _S._ Infantis: 51 weeks (evidenced by challenge) _S._ Hadar: 51 weeks (evidenced by challenge) _S._ Virchow: 51 weeks (drawn from scientific reasoning) _S._ Heidelberg: 57 weeks (drawn from scientific reasoning) 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccinate healthy animals only. 4.5 SPECIAL PRECAUTIO اقرأ الوثيقة كاملة